Opaleye Management Inc. Precigen, Inc. Transaction History

Opaleye Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $78,650 - $113,750	-65,000 Reduced 6.42%	947,500 $1.37 Million
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $74,760 - $118,440	84,000 Added 9.05%	1,012,500 $1.36 Million
Q3 2023 Nov 14, 2023	BUY	$1.08 - $1.85 $1 Million - $1.72 Million	928,500 New	928,500 $1.32 Million

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.